229 related articles for article (PubMed ID: 32946865)
21. Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma.
Xie Y; Ju X; Beaudin S; Wiltshire L; Oliveria JP; MacLean J; Sommer DD; Cusack R; Li O; Banerjee P; Keith PK; O'Byrne PM; Bauer RN; Staton T; Gauvreau GM; Sehmi R
Allergy; 2021 Sep; 76(9):2797-2808. PubMed ID: 33784411
[TBL] [Abstract][Full Text] [Related]
22. Effects of Blocking NLRP3 Inflammasome on Type II Innate Lymphoid Cell Response in Allergic Rhinitis.
Gong G; Huang P; Yang C; Huang C; Zhang Z; Chen R; Sun T; Yang G
Iran J Immunol; 2023 Sep; 3(20):287-302. PubMed ID: 37583131
[TBL] [Abstract][Full Text] [Related]
23. Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
Bui TT; Piao CH; Song CH; Chai OH
Int Immunopharmacol; 2017 Nov; 52():77-84. PubMed ID: 28886581
[TBL] [Abstract][Full Text] [Related]
24. lnc-THRIL and miR-125b relate to disease risk, severity, and imbalance of Th1 cells/Th2 cells in allergic rhinitis.
Song J; Liu D; Yin W
Allergol Immunopathol (Madr); 2022; 50(3):15-23. PubMed ID: 35527652
[TBL] [Abstract][Full Text] [Related]
25. Nonylphenol can aggravate allergic rhinitis in a murine model by regulating important Th cell subtypes and their associated cytokines.
Wang YX; Gu ZW; Cao ZW; Hao LY
Int Immunopharmacol; 2019 May; 70():260-267. PubMed ID: 30851706
[TBL] [Abstract][Full Text] [Related]
26. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
Piao CH; Song CH; Lee EJ; Chai OH
Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322
[TBL] [Abstract][Full Text] [Related]
27. Effects of Ursolic Acid on the Expression of Th1-Th2-related Cytokines in a Rat Model of Allergic Rhinitis After PM2.5 Exposure.
Sun N; Han Z; Wang H; Guo Z; Deng C; Dong W; Zhuang G; Zhang R
Am J Rhinol Allergy; 2020 Sep; 34(5):587-596. PubMed ID: 32208746
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA profiles in nasal mucosa of patients with allergic and nonallergic rhinitis and asthma.
Suojalehto H; Toskala E; Kilpeläinen M; Majuri ML; Mitts C; Lindström I; Puustinen A; Plosila T; Sipilä J; Wolff H; Alenius H
Int Forum Allergy Rhinol; 2013 Aug; 3(8):612-20. PubMed ID: 23704072
[TBL] [Abstract][Full Text] [Related]
29. IL2-inducible T-cell kinase inhibitor ibrutinib reduces symptoms and Th2 differentiation in mouse allergic-rhinitis model.
Xu B; Liu X; Gao S
Drug Dev Res; 2022 Apr; 83(2):544-551. PubMed ID: 34609751
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
31. Effects of myeloid and plasmacytoid dendritic cells on ILC2s in patients with allergic rhinitis.
Peng YQ; Qin ZL; Fang SB; Xu ZB; Zhang HY; Chen D; Liu Z; Bellanti JA; Zheng SG; Fu QL
J Allergy Clin Immunol; 2020 Mar; 145(3):855-867.e8. PubMed ID: 31812574
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-223-3p regulates allergic inflammation by targeting INPP4A.
Zhou Y; Zhang T; Yan Y; You B; You Y; Zhang W; Chen J
Braz J Otorhinolaryngol; 2021; 87(5):591-600. PubMed ID: 32631807
[TBL] [Abstract][Full Text] [Related]
33. [A review on group 2 innate lymphoid cells and miR-155 in allergic rhinitis].
Zhu YQ; Liu YH
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Dec; 31(24):1940-1943. PubMed ID: 29798323
[TBL] [Abstract][Full Text] [Related]
34. Symbiotic microbiome Staphylococcus epidermidis restricts IL-33 production in allergic nasal epithelium via limiting the cellular necroptosis.
Jeon YJ; Gil CH; Won J; Jo A; Kim HJ
BMC Microbiol; 2023 May; 23(1):154. PubMed ID: 37237381
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation.
Singh PB; Pua HH; Happ HC; Schneider C; von Moltke J; Locksley RM; Baumjohann D; Ansel KM
J Exp Med; 2017 Dec; 214(12):3627-3643. PubMed ID: 29122948
[TBL] [Abstract][Full Text] [Related]
36. Symbiotic microbiome Staphylococcus aureus from human nasal mucus modulates IL-33-mediated type 2 immune responses in allergic nasal mucosa.
Jeon YJ; Gil CH; Won J; Jo A; Kim HJ
BMC Microbiol; 2020 Oct; 20(1):301. PubMed ID: 33028252
[TBL] [Abstract][Full Text] [Related]
37. Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226.
Xie Y; Zhang Y; Liu Y; Wang Y; Cheng K; Zhuang R; Bian K
J Vis Exp; 2022 May; (183):. PubMed ID: 35635448
[TBL] [Abstract][Full Text] [Related]
38. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model.
Quan SH; Zhang YL; Han DH; Iwakura Y; Rhee CS
Ann Allergy Asthma Immunol; 2012 May; 108(5):342-50. PubMed ID: 22541406
[TBL] [Abstract][Full Text] [Related]
39. miR-375 prevents nasal mucosa cells from apoptosis and ameliorates allergic rhinitis via inhibiting JAK2/STAT3 pathway.
Wang T; Chen D; Wang P; Xu Z; Li Y
Biomed Pharmacother; 2018 Jul; 103():621-627. PubMed ID: 29677549
[TBL] [Abstract][Full Text] [Related]
40. Epithelial cell-derived micro RNA-146a generates interleukin-10-producing monocytes to inhibit nasal allergy.
Luo X; Han M; Liu J; Wang Y; Luo X; Zheng J; Wang S; Liu Z; Liu D; Yang PC; Li H
Sci Rep; 2015 Nov; 5():15937. PubMed ID: 26526003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
